Alexandria Voigt

Alexandria Voigt

Auto-generated profile, based on publicly available information

Alexandria Voigt

Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida , Gainesville, FL

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AVAlexandria Voigt
Alexandria Voigt
LELida Esfandiary
Lida Esfandiary
AWArun Wanchoo
Arun Wanchoo
PGPatricia Glenton
Patricia Glenton
ADAmy Donate
Amy Donate
CNCuong Nguyen
Cuong Nguyen
Interleukin (IL)-17 is one of the critical inflammatory cytokines that plays a direct role in development of Sjögren’s syndrome (SjS), a systemic autoimmune disease characterized by a progressive chronic attack against the exocrine glands. The expression levels of IL-17 are correlated with a number of essential clinical parameters such as focus score and disease duration in human patients. Significantly immunological differences of Th17 cells were detected at the onset of clinical disease in female SjS mice compared to males. To further define the role of IL-17 in SjS and elucidate its involvement in the sexual dimorphism, we examined the systemic effect of IL-17 by genetically ablating Il-17 in the C57BL/6.NOD-Aec1Aec2, spontaneous SjS murine model. The results indicate that IL-17 is a potent inflammatory molecule in the induction of chemoattractants, cytokines, and glandular apoptosis in males and females. Elimination of IL-17 reduced sialadenitis more drastically in females than males. IL-17 is highly involved in modulating Th2 cytokines and altering autoantibody profiles which has a greater impact on changing plasma cells and germinal center B cell populations in females than males. The result supports a much more important role for IL-17 and demonstrates the sexual dimorphic function of IL-17 in SjS.

1 July 2018 in Clinical Immunology
Verified
Journal Article
Closed access
AVAlexandria Voigt
Alexandria Voigt
KBKatherine Bohn
Katherine Bohn
SSSukesh Sukumaran
Sukesh Sukumaran
CSCarol M. Stewart
Carol M. Stewart
IBIndraneel Bhattacharya
Indraneel Bhattacharya
CNCuong Nguyen
Cuong Nguyen

10 February 2014 in Expert Review of Clinical Immunology
Verified
Journal Article
Closed access
ADAmy Donate
Amy Donate
AVAlexandria Voigt
Alexandria Voigt
CNCuong Nguyen
Cuong Nguyen
(2014). The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms. Expert Review of Clinical Immunology: Vol. 10, No. 4, pp. 469-481.

19 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HYHongen Yin
Hongen Yin
LKLovika Kalra
Lovika Kalra
ZLZhennan Lai
Zhennan Lai
MGMaria C. Guimaro
Maria C. Guimaro
LALauren Aber
Lauren Aber
JCJohn A. Chiorini
John A. Chiorini
Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease, with only palliative treatments available. Recent work has suggested that increased bone morphogenetic protein 6 (BMP6) expression could alter cell signaling in the salivary gland (SG) and result in the associated salivary hypofunction. We examined the prevalence of elevated BMP6 expression in a large cohort of pSS patients and tested the therapeutic efficacy of BMP signaling inhibitors in two pSS animal models. Increased BMP6 expression was found in the SGs of 54% of pSS patients, and this increased expression was correlated with low unstimulated whole saliva flow rate. In mouse models of SS, inhibition of BMP6 signaling reduced phosphorylation of SMAD1/5/8 in the mouse submandibular glands, and led to a recovery of SG function and a decrease in inflammatory markers in the mice. The recovery of SG function after inhibition of BMP6 signaling suggests cellular plasticity within the salivary gland and a possibility for therapeutic intervention that can reverse the loss of function in pSS.

2 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AWArun Wanchoo
Arun Wanchoo
AVAlexandria Voigt
Alexandria Voigt
SSSukesh Sukumaran
Sukesh Sukumaran
CSCarol M. Stewart
Carol M. Stewart
IBIndraneel Bhattacharya
Indraneel Bhattacharya
CNCuong Nguyen
Cuong Nguyen
The development of Sjögren’s syndrome (SjS) is a dynamic and temporal process with a female predilection. Following the initial influx of immune cells, T cell clusters develop, accelerating the pathology in the salivary glands. Proinflammatory cytokines, IFN-γ and IL-17A, produced by T cells contribute synergistically to the disease. In this study, we examined the sexual dimorphism in cellular infiltrates of the salivary glands by using functional single-cell microengraving analysis. Using high-throughput sequencing, we investigated the clonal diversity of the T cell receptors (TCRs) of infiltrating IFN-γ and IL-17A-producing T cells in male and female SjS-susceptible (SjSs) C57BL/6.NOD-Aec1Aec2mice. There were elevated frequencies of IFN-γ and IL-17A-producing effector T cell populations in female SjSSmice compared to male SjSSmice. MEME analysis shows high frequency and unique, sexually dimorphic motifs in the TCR hypervariable regions in the SjSSmice. Male mice selected for TRAV8/TRAJ52 (CATDLNTGANTGKLTFG) TCR genes in Th1 cells and TRBV16/(TRBD1/2)TRBJ1-7 (CGGKRRLESIFR) in Th1 and Th17 cells. Female SjSSmice selected for TRAV8/TRAJ52 (CATDLNTGANTGKLTFG), TRAV13D-2/TRAJ23 (CVYLEHHFE), and TRBV23/(TRBD2)TRBJ2-2 (CRKLHSCATCALNFL) in Th1 cells. These findings suggest that there is an elevated prevalence of pathogenic effector T cells in the glands with a sexually dimorphic selection bias of TCR repertoires.

9 October 2015 in Biology Open
Verified
Journal Article
Open access
PDF file
AVAlexandria Voigt
Alexandria Voigt
LELida Esfandiary
Lida Esfandiary
CNCuong Nguyen
Cuong Nguyen
Sjögren9s syndrome is a complex autoimmune disease with an array of diverse immunological, genetic and environmental etiologies, making identification of the precise autoimmune mechanism difficult to define. One of the most distinctive aspects of Sjögren9s syndrome is the high sexual dimorphism with women affected 10-20 times more than men. It is nearly impossible to study the sexual dimorphic development of Sjögren9s syndrome in human patients; therefore it is pertinent to develop an appropriate animal model which resembles human disease. The data indicated that female C57BL/6.NOD-Aec1Aec2 mice developed an earlier onset of sialadenitis with a higher composition of CD3+ T cells and a 10-fold increase in glandular infiltration of Th17 cells at the onset of clinical disease compared to male mice. Inflammatory Th17 cells of female mice exhibited a stronger proliferation in response to disease-specific antigen than their male counterpart. At the clinical disease stage, altered autoantibody patterns can be detected in females whereas they are seldom observed in male C57BL/6.NOD-Aec1Aec2 mice. Interestingly, male C57BL/6.NOD-Aec1Aec2 mice developed an earlier loss of secretory function, despite the fact that female C57BL/6.NOD-Aec1Aec2 mice exhibited a more rapid secretory loss. This data indicates the strong sexual dimorphism in the SjS-susceptible C57BL/6.NOD-Aec1Aec2 animal model, making it an appropriate animal model to examine human disease.